Back
Pacira BioSciences Stock Price Chart
Sponsored
PCRX
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
PCRX
Pacira BioSciences
Last Price:
14.71
Seasonality Move:
-2.82%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- The current trend is relatively stagnant and PCRX is experiencing slight selling pressure.
Pacira BioSciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.47 | Buy |
20-day SMA: | 14.17 | Buy |
50-day SMA: | 16.86 | Sell |
200-day SMA: | 26.29 | Sell |
8-day EMA: | 13.9 | Buy |
20-day EMA: | 14.37 | Buy |
50-day EMA: | 17.04 | Sell |
200-day EMA: | 24.96 | Sell |
Pacira BioSciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 47.85 | Sell |
Chaikin Money Flow: | -36437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.15 - 14.85) | Buy |
Bollinger Bands (100): | (16.05 - 29.01) | Sell |
Pacira BioSciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pacira BioSciences Stock
Is Pacira BioSciences Stock a Buy?
- Pacira BioSciences share price is 14.64 while PCRX 8-day simple moving average is 13.47, which is a Buy signal.
- The stock price of PCRX is 14.64 while Pacira BioSciences 20-day SMA is 14.17, which makes it a Buy.
- Pacira BioSciences 50-day simple moving average is 16.86 while PCRX share price is 14.64, making it a Sell technically.
- PCRX stock price is 14.64 and Pacira BioSciences 200-day simple moving average is 26.29, creating a Sell signal.
PCRX Technical Analysis vs Fundamental Analysis
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy or a Sell?
-
Pacira BioSciences stock is rated a Sell
The current Pacira BioSciences [PCRX] share price is $14.64. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Pacira BioSciences Stock Info
Market Cap:
675.3M
Price in USD:
14.64
Share Volume:
817.44K
Pacira BioSciences 52-Week Range
52-Week High:
35.95
52-Week Low:
11.16
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Pacira BioSciences Share Price Forecast
-
What is the Pacira BioSciences stock price today?
The Pacira BioSciences stock price is 14.64 USD today. -
Will PCRX stock go up or go down?
Pacira BioSciences> share price is forecast to RISE/FALL based on technical indicators -
Is Pacira BioSciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pacira BioSciences is overvalued.
Is Pacira BioSciences Stock a Buy?
- Pacira BioSciences share price is 14.64 while PCRX 8-day exponential moving average is 13.90, which is a Buy signal.
- The stock price of PCRX is 14.64 while Pacira BioSciences 20-day EMA is 14.37, which makes it a Buy.
- Pacira BioSciences 50-day exponential moving average is 17.04 while PCRX share price is 14.64, making it a Sell technically.
- PCRX stock price is 14.64 and Pacira BioSciences 200-day simple moving average is 24.96, creating a Sell signal.
Fundamental Analysis of Pacira BioSciences
Is Pacira BioSciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.
Technical Analysis of Pacira BioSciences
Should I short Pacira BioSciences stock?
- PCRX Moving Average Covergence Divergence (MACD) indicator is -0.87, suggesting Pacira BioSciences is a Sell
- Pacira BioSciences Relative Strength Index (RSI) is 47.85, which suggest Pacira BioSciences is oversold
- The Bollinger Bands (25) for Pacira BioSciences is (13.15 - 14.85), which suggest Pacira BioSciences is a Sell
- The Bollinger Bands (100) for Pacira BioSciences is (16.05 - 29.01), which suggest Pacira BioSciences is a Sell
* Pacira BioSciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.